Posaconazole 100mg gastro-resistant tablets
NHS hospitals in England used £63,466,522 of indicative cost of Posaconazole 100mg gastro-resistant tablets in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 4.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Posaconazole 100mg gastro-resistant tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Posaconazole 100mg gastro-resistant tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £3,612,786 |
| Manchester University Nhs Ft | £3,178,386 |
| Cambridge Univ Hosp Nhs Foundation Trust | £2,577,089 |
| University College London Foundation Tr | £2,462,572 |
| The Royal Marsden Nhs Foundation Trust | £2,315,436 |
| King's College Hpl Nhs Foundation Trust | £1,928,949 |
| The Christie Nhs Foundation Trust | £1,903,883 |
| Western Sussex Hospitals Nhs Found Trust | £1,638,177 |
| Sheffield Teaching Hospitals Nhs Trust | £1,569,176 |
| The Clatterbridge Cancer Centre Nhs Ft | £1,556,660 |
The primary-care picture
Posaconazole is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Posaconazole medicine page.